Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07302503Recruiting
MRI study of brain changes in footballers
This study uses a special type of MRI scan to look for tiny changes in the brain's wiring that can happen after head impacts. It compares professional footballers to people who haven't played sports with head impacts, to see if these changes show up on the scan.
StrasbourgAges 32–60 - NCT07301476Recruiting
Testing numbing medicine spread in a knee block
This trial checks how a numbing medicine moves during a common knee block for surgery. It may help doctors improve pain control after knee operations.
Boulogne-BillancourtAges 18 years+ - NCT07306013Recruiting
SolanoConnex mental health access trial
This trial tests a digital platform to help people with mild to moderate mental health symptoms get connected to care. If you live in Solano County, have a smartphone, and haven't used the platform before, you may be able to join.
Vallejo, CaliforniaAges 18 years+ - NCT05947344RecruitingPhase 1
Testing STI-8591 for advanced acute myeloid leukemia
This early-stage study tests STI-8591 in people with advanced acute myeloid leukemia (AML) or certain related blood cancers. It mainly aims to find a safe dose and see whether the treatment can work for patients whose disease did not respond to standard care or who cannot get it.
Hangzhou, ZhejiangAges 18 years+ - NCT06238076Recruiting
Universal surgical device for jaw reconstruction
This trial tests a universal surgical device for rebuilding the lower jaw using a bone flap from the leg. It aims to make the procedure more reliable and easier for patients needing reconstruction of the front part of the jaw.
ToulouseAges 18 years+ - NCT06488313RecruitingPhase 2
Study of ARCT-810 for people with OTC deficiency
This trial tests an experimental medicine called ARCT-810 for people with Ornithine Transcarbamylase (OTC) deficiency, a condition that affects the liver's ability to remove ammonia from the body. The study aims to see if ARCT-810 can help lower ammonia levels safely.
Chevy Chase, MarylandAges 12 years+ - NCT06530641RecruitingPhase 4
Comparing heart protection solutions during major heart surgery
This trial compares two types of cardioplegia (a solution that stops your heart during surgery) to see which one leads to better outcomes. It is for adults undergoing major heart surgery with a heart-lung machine.
Madrid, MadridAges 18 years+ - NCT06738758Recruiting
Early intensive cholesterol-lowering study for acute coronary syndrome
This study tests whether starting strong cholesterol-lowering treatment early in the hospital can improve outcomes for people with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina). It may help if you have high LDL cholesterol.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06849609RecruitingEarly Phase 1
Gene therapy VGN-R13 for ALS safety and tolerability
This study tests a new gene therapy called VGN-R13 for people with ALS. It aims to see if the treatment is safe and tolerable, and if it can slow down the disease. You may be able to join if your ALS symptoms started recently and your lung function is still fairly good.
Wuhan, HubeiAges 18 years+ - NCT06711276Recruiting
Testing a new injury scoring system for blunt trauma patients
This study is testing how well a new scoring system (called NISS) measures the severity of injuries after a blunt trauma, like a car crash or fall. By using this score soon after you arrive, doctors hope to better predict your recovery and care needs.
BaghdadAges 18 years+ - NCT06875193RecruitingPhase 4
Comparing dapagliflozin vs pioglitazone for type 2 diabetes
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
SeoulAges 19 years+ - NCT06879730Recruiting
Studying surgery types for early-stage ovarian cancer
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
Varese, VareseAges Any age - NCT07293455Recruiting
Testing new TB diagnostic tools for Indonesia
This study tests new ways to diagnose tuberculosis (TB) in both children and adults who have symptoms like a long-lasting cough. It aims to find better tools to detect TB early and help people get the right treatment faster.
Bandung, West JavaAges 4 weeks+ - NCT07289412Recruiting
Meniscus repair study with or without ligament surgery
This study looks at how well meniscus repairs (using the all-inside technique) work over time, both when done alone and when combined with ligament reconstruction. It may help you understand the success of this surgery for your knee.
BolognaAges 12–65 - NCT07290179Recruiting
Can a smartwatch detect when kids eat?
This study tests if a smartwatch can automatically sense when children are eating. You and your child will wear the watch for three days to see if it works in real life.
Baton Rouge, LouisianaAges 8–12 - NCT07292584Recruiting
Digital toolkit to help women start PrEP
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
Birmingham, AlabamaAges 18 years+ - NCT07295457Recruiting
Exercise to prevent pain from hormone therapy in breast cancer
This trial tests whether starting a gentle exercise program early can help prevent or reduce joint and muscle pain caused by aromatase inhibitors (a common breast cancer medicine). It is for women with hormone-sensitive breast cancer who are not yet experiencing severe pain from their treatment.
LyonAges 18–75 - NCT07292571Enrolling by invitationPhase 2
Tracing breast cancer HER2 with a special scan
This study uses a radioactive tracer to see how much HER2 protein is on your breast cancer cells. The scan may help doctors understand the type of HER2 you have and choose the best treatment.
TomskAges 18–80 - NCT07292987Recruiting
Support program for people newly diagnosed with retinitis pigmentosa
This study is testing a new way to support people who have just been told they have retinitis pigmentosa (RP) at the Quinze-Vingts hospital in Paris. It aims to help you understand your diagnosis and get the care you need.
Paris, Île-de-France RegionAges 18–65 - NCT07289932Enrolling by invitation
Peptide vs fluoride varnish for white spots on teeth
This study compares a new peptide treatment to a standard fluoride varnish for reversing small white spots on teeth (early cavities) in teens and young adults. You’ll receive one treatment on one side of your mouth and the other treatment on the other side, and we’ll see which works better.
CairoAges 15–25 - NCT07294625RecruitingEarly Phase 1
Gene therapy for relapsed/refractory multiple myeloma
This trial tests a new gene therapy, LVIVO-TaVec200, for people with multiple myeloma that has returned or not responded to other treatments. The goal is to see if it can help control the cancer.
Zhengzhou, HenanAges 18 years+ - NCT07293533Enrolling by invitation
Heart bypass risk study for planned surgeries
This study looks at patient data from people who had a planned coronary artery bypass graft (heart bypass) to create a better way to predict risks. It may help future patients understand their own surgery risks.
Fortaleza, CearáAges 18 years+ - NCT07296458RecruitingPhase 3
Fenofibrate for first-line treatment of primary biliary cholangitis
This study tests whether fenofibrate, a medicine that lowers fats in the blood, can help people with primary biliary cholangitis (a chronic liver disease) who haven't had treatment before. It aims to see if it is safe and effective as a first treatment option.
Xi'an, ShaanxiAges 18–75 - NCT07294508RecruitingPhase 2/Phase 3
Testing a new drug combo for HER2-positive advanced breast cancer
This trial tests two study drugs, HLX22 and HLX87, together for people with HER2-positive breast cancer that has spread or come back. It may be an option if you haven't yet had chemotherapy or HER2-targeted therapy for advanced disease.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.